Source:http://linkedlifedata.com/resource/pubmed/id/19335204
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0029347,
umls-concept:C0033684,
umls-concept:C0042776,
umls-concept:C0181904,
umls-concept:C0205265,
umls-concept:C0331858,
umls-concept:C0596972,
umls-concept:C0728873,
umls-concept:C1521743,
umls-concept:C1555582,
umls-concept:C1704640,
umls-concept:C1704646,
umls-concept:C1706515
|
pubmed:issue |
5-6
|
pubmed:dateCreated |
2009-5-27
|
pubmed:abstractText |
The uptake of influenza A viruses (IAV) into cells represents an attractive antiviral drug target, e.g., by interfering with essential cellular or viral entry factors. So far, this process could only be studied by time-consuming microscopical methods. Thus, there is a lack of rapid and easy assay systems to monitor viral entry. Here, we describe a rapid procedure to analyse internalisation of IAV via Western blot detection of virion-associated matrix protein (M1), the most abundant protein within the viral particle. The assay is broadly applicable and detects different virus strains of various subtypes. As a proof of principle, treatment of cells with various known or presumed entry inhibitors resulted in reduced M1 levels. Removal of sialic acids, the receptors for IAV, led to a complete loss of the M1 signal, indicating that virus internalisation can be monitored already at the stage of attachment. Prevention of endosomal acidification resulted in a delayed degradation of M1 indicative of IAV particles trapped in endosomes. Thus, early detection of the virus-associated M1 protein is a rapid method to monitor different steps of influenza virus internalisation and has potential for application as a screening method for drugs that interfere with the uptake of IAV.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1431-6730
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
390
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
509-15
|
pubmed:meshHeading |
pubmed-meshheading:19335204-Animals,
pubmed-meshheading:19335204-Blotting, Western,
pubmed-meshheading:19335204-Cell Line,
pubmed-meshheading:19335204-Humans,
pubmed-meshheading:19335204-Influenza, Human,
pubmed-meshheading:19335204-Influenza A Virus, H1N1 Subtype,
pubmed-meshheading:19335204-Influenza A Virus, H3N2 Subtype,
pubmed-meshheading:19335204-Influenza A Virus, H7N7 Subtype,
pubmed-meshheading:19335204-Influenza A virus,
pubmed-meshheading:19335204-Viral Matrix Proteins,
pubmed-meshheading:19335204-Virus Internalization
|
pubmed:articleTitle |
The influenza A virus matrix protein as a marker to monitor initial virus internalisation.
|
pubmed:affiliation |
Institute of Molecular Virology, Westfälische Wilhelms University, Von Esmarch-Str. 56, D-48149 Münster, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|